According to Trevena's latest financial reports and stock price the company's current number of shares outstanding is 13,964,301. At the end of 2023 the company had 13,964,301 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 13.96 M | 45.55% |
2022 | 9.59 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Amgen AMGN | 535,000,000 | 3,731.20% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 18,190.69% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | 38,562,800 | 176.15% | ๐บ๐ธ USA |
Cytokinetics
CYTK | 99,067,000 | 609.43% | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | 16,758,322 | 20.01% | ๐บ๐ธ USA |
Cara Therapeutics
CARA | 54,235,695 | 288.39% | ๐บ๐ธ USA |
Arena Pharmaceuticals
ARNA | 56,662,000 | 305.76% | ๐บ๐ธ USA |